Moderna
MRNA
#298
Rank
NZ$142.54 B
Marketcap
NZ$352.29
Share price
-3.16%
Change (1 day)
717.99%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Thumbnail Moderna
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report